![Gustav Gaudernack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gustav Gaudernack
Keine laufenden Positionen mehr
Health Technology
Profil
Gustav Gaudernack is the founder of Circio Holding ASA, which was founded in 2010.
Currently, he is the Chief Scientific Officer at Ultimovacs ASA. Previously, he worked as a Professor at Norwegian Radium Hospital from 1995 to 2011.
Ehemalige bekannte Positionen von Gustav Gaudernack
| Unternehmen | Position | Ende |
|---|---|---|
Norwegian Radium Hospital | Corporate Officer/Principal | 01.01.2011 |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Technik-/Wissenschafts-/F&E-Leiter | - |
| CIRCIO HOLDING ASA | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Norwegian Radium Hospital |
